share_log

上海医药:硝酸异山梨酯注射液通过仿制药一致性评价

SH PHARMA: Isosorbide Dinitrate Injection has passed the consistency evaluation of generic drugs.

Breakings ·  Jan 2 16:48

SH PHARMA announced that its wholly-owned subsidiary, SH PHARMA First Biochemical Pharmaceutical Co., Ltd., has had Isosorbide Dinitrate Injection pass the consistency evaluation of the quality and efficacy of generic drugs. This Pharmaceutical is mainly used in the treatment of unstable angina, with a hospital procurement amount of 0.907 billion yuan in 2023. Passing the evaluation is beneficial for expanding market share and enhancing competitiveness, but due to policy and market environment influences, sales are subject to uncertainty.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment